GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Provided By GlobeNewswire
Last update: Aug 14, 2025
Live video webcast on Wednesday, August 20th at 2:20 PM ET
LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025.
Read more at globenewswire.com
